Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.

von Hardenberg J, Martini T, Knauer A, Ströbel P, Becker A, Herrmann E, Schubert C, Steidler A, Bolenz C.

Urol Oncol. 2014 Jan;32(1):54.e9-17. doi: 10.1016/j.urolonc.2013.08.031.

PMID:
24360666
[PubMed - in process]
2.

The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.

Bolenz C, Auer M, Ströbel P, Heinzelbecker J, Schubert C, Trojan L.

Urol Oncol. 2013 Nov;31(8):1606-14. doi: 10.1016/j.urolonc.2012.02.012. Epub 2012 Apr 13.

PMID:
22503575
[PubMed - indexed for MEDLINE]
3.

Twist modulates lymphangiogenesis and correlates with lymph node metastasis in supraglottic carcinoma.

Lu SM, Yu L, Tian JJ, Ma JK, Li JF, Xu W, Wang HB.

Chin Med J (Engl). 2011 May;124(10):1483-7.

PMID:
21740802
[PubMed - indexed for MEDLINE]
Free Article
4.

Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.

Suzuki K, Morita T, Tokue A.

Int J Urol. 2005 Feb;12(2):152-8.

PMID:
15733109
[PubMed - indexed for MEDLINE]
5.

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.

Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L.

BJU Int. 2010 Aug;106(4):493-9. doi: 10.1111/j.1464-410X.2009.09166.x. Epub 2010 Jan 8.

PMID:
20067452
[PubMed - indexed for MEDLINE]
6.

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.

Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Höcker M.

J Clin Oncol. 2006 Jan 10;24(2):228-40. Epub 2005 Dec 12.

PMID:
16344322
[PubMed - indexed for MEDLINE]
7.

Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis.

Yan C, Zhu ZG, Yu YY, Ji J, Zhang Y, Ji YB, Yan M, Chen J, Liu BY, Yin HR, Lin YZ.

World J Gastroenterol. 2004 Mar 15;10(6):783-90.

PMID:
15040017
[PubMed - indexed for MEDLINE]
Free Article
8.

Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.

Wang XL, Fang JP, Tang RY, Chen XM.

BMC Cancer. 2010 Jun 17;10:299. doi: 10.1186/1471-2407-10-299.

PMID:
20565772
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.

Aktuelle Urol. 2007 Sep;38(5):392-7. German.

PMID:
17907066
[PubMed - indexed for MEDLINE]
10.

Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.

Ma Y, Hou Y, Liu B, Li X, Yang S, Ma J.

Anat Rec (Hoboken). 2010 Nov;293(11):1847-54. doi: 10.1002/ar.21217.

PMID:
20730866
[PubMed - indexed for MEDLINE]
Free Article
11.

Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma.

Choi JH, Oh YH, Park YW, Baik HK, Lee YY, Kim IS.

J Korean Med Sci. 2008 Aug;23(4):592-7. doi: 10.3346/jkms.2008.23.4.592.

PMID:
18756043
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.

da Silva RD, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Chade D, Guglielmetti GB, Pycha A, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Zerbib M, Scherr DS, Shariat SF.

J Urol. 2013 Aug;190(2):487-92. doi: 10.1016/j.juro.2013.02.003. Epub 2013 Feb 8.

PMID:
23395802
[PubMed - indexed for MEDLINE]
13.

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M.

Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.

PMID:
23217567
[PubMed - indexed for MEDLINE]
14.

Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Zhao YC, Ni XJ, Li Y, Dai M, Yuan ZX, Zhu YY, Luo CY.

World J Surg Oncol. 2012 Aug 20;10:165. doi: 10.1186/1477-7819-10-165.

PMID:
22906075
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.

Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y.

BJU Int. 2010 May;105(10):1402-12. doi: 10.1111/j.1464-410X.2010.09217.x. Epub 2010 Feb 2.

PMID:
20132195
[PubMed - indexed for MEDLINE]
16.

[Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].

Wang XL, Ai ZS, Fang JP, Tang RY, Chen XM.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):837-43. Chinese.

PMID:
19173829
[PubMed - indexed for MEDLINE]
17.

The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.

Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M, Tomazewski J, Vaughn D, Van Arsdalen K, Malkowicz B.

BJU Int. 2008 Sep;102(8):952-7. doi: 10.1111/j.1464-410X.2008.07732.x. Epub 2008 May 15.

PMID:
18485042
[PubMed - indexed for MEDLINE]
18.

Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.

Feng Y, Wang W, Hu J, Ma J, Zhang Y, Zhang J.

Anat Rec (Hoboken). 2010 May;293(5):802-12. doi: 10.1002/ar.21096.

PMID:
20225197
[PubMed - indexed for MEDLINE]
Free Article
19.

Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.

Hautmann RE, de Petriconi RC, Pfeiffer C, Volkmer BG.

Eur Urol. 2012 May;61(5):1039-47. doi: 10.1016/j.eururo.2012.02.028. Epub 2012 Feb 22.

PMID:
22381169
[PubMed - indexed for MEDLINE]
20.

Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.

Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A.

BJU Int. 2013 Jun;111(8):1215-21. doi: 10.1111/j.1464-410X.2012.11455.x. Epub 2012 Nov 26.

PMID:
23181623
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk